Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid van der Heijden

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
NPJ Breast Cancer|May 6, 2022
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistanceMarlous Hoogstraat, Esther H Lips, Isabel Mayayo-Peralta, et al.
Cancer Cell|December 17, 2011
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistanceRinske Drost, Peter Bouwman, Sven Rottenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2007
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancerSven Rottenberg, Anders O H Nygren, Marina Pajic, et al.
Oncoimmunology|March 3, 2020
Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune systemSjoerd Klarenbeek, Chris W Doornebal, Sjors M Kas, et al.
Science Advances|May 31, 2023
FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinksAbdelghani Mazouzi, Sarah C Moser, Federico Abascal, et al.
The Biochemical Journal|May 3, 2007
Multidrug resistance-associated protein 9 (ABCC12) is present in mouse and boar spermNobuhito Ono, Ingrid Van der Heijden, George L Scheffer, et al.
Molecular Cell|September 23, 2021
Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gapsMariana Paes Dias, Vivek Tripathi, Ingrid van der Heijden, et al.
Nature|August 2, 2019
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasisMax D Wellenstein, Seth B Coffelt, Danique E M Duits, et al.
Cell Reports|May 20, 2023
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumorsJinhyuk Bhin, Mariana Paes Dias, Ewa Gogola, et al.
The Journal of Clinical Investigation|July 26, 2016
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1Rinske Drost, Kiranjit K Dhillon, Hanneke van der Gulden, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
NPJ Breast Cancer|May 6, 2022
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistanceMarlous Hoogstraat, Esther H Lips, Isabel Mayayo-Peralta, et al.
Cancer Cell|December 17, 2011
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistanceRinske Drost, Peter Bouwman, Sven Rottenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2007
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancerSven Rottenberg, Anders O H Nygren, Marina Pajic, et al.
Oncoimmunology|March 3, 2020
Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune systemSjoerd Klarenbeek, Chris W Doornebal, Sjors M Kas, et al.
Science Advances|May 31, 2023
FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinksAbdelghani Mazouzi, Sarah C Moser, Federico Abascal, et al.
The Biochemical Journal|May 3, 2007
Multidrug resistance-associated protein 9 (ABCC12) is present in mouse and boar spermNobuhito Ono, Ingrid Van der Heijden, George L Scheffer, et al.
Molecular Cell|September 23, 2021
Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gapsMariana Paes Dias, Vivek Tripathi, Ingrid van der Heijden, et al.
Nature|August 2, 2019
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasisMax D Wellenstein, Seth B Coffelt, Danique E M Duits, et al.
Cell Reports|May 20, 2023
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumorsJinhyuk Bhin, Mariana Paes Dias, Ewa Gogola, et al.
The Journal of Clinical Investigation|July 26, 2016
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1Rinske Drost, Kiranjit K Dhillon, Hanneke van der Gulden, et al.
Pageof 4